We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.


At Taylor & Francis we are dedicated to advancing knowledge by publishing trusted, engaging and insightful research. We publish high impact journals delivering quality information to the global pain research community. Read on for more information on our journals as well as the different publishing options we offer.

Looking to publish your research?

Get in touch with one of our expert editors to discuss your work or visit our dedicated author services site filled with information to support you through the publication process.

Current Medical Research and Opinion

MEDLINE-Indexed. IF 2.665.

Visit Journal Articles

Expert Review of Neurotherapeutics

MEDLINE-Indexed. IF 3.692.

Visit Journal Articles

Postgraduate Medicine

MEDLINE-Indexed. IF 2.057.

Visit Journal Articles

Hospital Practice


Visit Journal Articles

Open Access

Why publish Open Access?

Open Access provides you with the following great benefits:

  • Immediate access to your article on publication, accessible by anyone, anywhere
  • High visibility and discoverability via Taylor & Francis Online
  • Input from, and dialog with, expert editors
  • Rigorous peer review for every open access article
  • Metrics (downloads, citations, and Altmetric data) for your article, so you can measure its impact

Want to know more about Open Access? 

Find out more

Accelerated Publication

If time is critical in your publishing strategy, our Accelerated Publication options can help you get your research into a high-quality, peer-reviewed journal, fast.

Accelerated Publication allows you to:

  • coordinate your publishing schedule with conferences, drug approvals, and drug launches,
  • keep competitive advantage by getting your discoveries to market quickly,
  • and speed up the peer review process without sacrificing quality or rigour.

Find out more

Latest Tweets